Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer

Decera Clinical Education Oncology Podcast · Dec 26, 2023 · 8m

This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs.

Presenters in this series include:

Rebecca S. Heist, MD, MPH

Associate Professor of Medicine

Harvard Medical School

Medical Oncology

Massachusetts General Hospital

Boston, Massachusetts

Helena Yu, MD

Associate Attending

Department of Medicine

Memorial Sloan Kettering Cancer Center

New York, New York

Supported by an educational grant from Daiichi Sankyo, Inc.

Link to full program, including a downloadable highlights slideset…